Article
Primary CD34 <sup>+</sup> cells of patients with VEXAS syndrome are highly sensitive to targeted treatment with TAK-243 and pevonedistat
2025-05-24
Abstract excerpt
Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) syndrome is an autoinflammatory disease characterized by somatically acquired UBA1 mutations in hematopoietic stem cells. VEXAS patients present with significant therapeutic challenges such as severe treatment-resistant inflammation and predisposition to myeloid malignancies. In this study, we evaluated the efficacy of TAK-243, a UBA1 inhibitor, and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 37abce78-0fd6-5774-bbd5-2bac0564a8cb
- DOI
- 10.1101/2025.05.22.653244
